Literature DB >> 27639685

Comparison of Quantity of Calcific Deposits by Multidetector Computed Tomography in the Aortic Valve and Coronary Arteries.

Philippe J van Rosendael1, Vasileios Kamperidis2, William K F Kong3, Alexander R van Rosendael4, Nina A Marsan1, Jeroen J Bax1, Victoria Delgado5.   

Abstract

The aim of this study was to compare the calcium burden of the aortic valve and coronary arteries with multidetector computed tomography (MDCT) in a propensity score-matched population of patients with a bicuspid versus a tricuspid aortic valve. From an ongoing clinical registry of patients who underwent MDCT, 70 patients with bicuspid aortic valve and 210 patients with tricuspid aortic valve were matched based on age, gender, cardiovascular risk factors, chest pain symptoms, and MDCT indication. Aortic valve calcium and the presence and severity of coronary artery disease were analyzed. Patients were divided into age quintiles. The median Agatston coronary artery score (27 [0 to 563] vs 0 [0 to 57], p = 0.003) was higher in patients with a tricuspid aortic valve compared with those with a bicuspid aortic valve. In contrast, patients with bicuspid aortic valve had a significantly larger calcium volume of the aortic valve than those with tricuspid aortic valve (391 [43 to 2,028] mm3 vs 0 [0 to 1,844] mm3, p <0.001). In patients with bicuspid aortic valve, the calcification process of the aortic valve started at an earlier age (second quintile 35 to 51 years) compared with those with tricuspid aortic valve, whereas the coronary atherosclerosis process was similar in both groups. In conclusion, patients with bicuspid aortic valve show larger aortic valve calcium load and at earlier age than those with tricuspid aortic valve, independently from the extent of calcium in the coronary arteries. Calcific deposits were heavier in bicuspid than in tricuspid valves.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27639685     DOI: 10.1016/j.amjcard.2016.08.021

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

1.  Increased Calcific Aortic Valve Disease in response to a diabetogenic, procalcific diet in the LDLr-/-ApoB100/100 mouse model.

Authors:  Marta Scatena; Melissa F Jackson; Mei Y Speer; Elizabeth M Leaf; Mary C Wallingford; Cecilia M Giachelli
Journal:  Cardiovasc Pathol       Date:  2018-02-15       Impact factor: 2.185

Review 2.  Transcatheter aortic valve implantation in patients with bicuspid valve morphology: a roadmap towards standardization.

Authors:  Tian-Yuan Xiong; Walid Ben Ali; Yuan Feng; Kentaro Hayashida; Hasan Jilaihawi; Azeem Latib; Michael Kang-Yin Lee; Martin B Leon; Raj R Makkar; Thomas Modine; Christoph Naber; Yong Peng; Nicolo Piazza; Michael J Reardon; Simon Redwood; Ashok Seth; Lars Sondergaard; Edgar Tay; Didier Tchetche; Wei-Hsian Yin; Mao Chen; Bernard Prendergast; Darren Mylotte
Journal:  Nat Rev Cardiol       Date:  2022-06-20       Impact factor: 32.419

3.  Comparative evaluation of coronary disease burden: bicuspid valve disease is not atheroprotective.

Authors:  Jan H N Lindeman; Nimrat Grewal; Onur Baris Dolmaci; Antoine H G Driessen; Robert J M Klautz; Robert Poelmann
Journal:  Open Heart       Date:  2021-09

Review 4.  Bicuspid Aortic Valve Stenosis: From Pathophysiological Mechanism, Imaging Diagnosis, to Clinical Treatment Methods.

Authors:  Nils Perrin; Réda Ibrahim; Nicolas Dürrleman; Arsène Basmadjian; Lionel Leroux; Philippe Demers; Thomas Modine; Walid Ben Ali
Journal:  Front Cardiovasc Med       Date:  2022-02-08

5.  Predictors of post-TAVI conduction abnormalities in patients with bicuspid aortic valves.

Authors:  Giulia Esposito; Niraj Kumar; Francesca Pugliese; Max Sayers; Anthony Wc Chow; Simon Kennon; Mick Ozkor; Anthony Mathur; Andreas Baumbach; Guy Lloyd; Aigerim Mullen; Andrew Cook; Michael Mullen; Kush P Patel
Journal:  Open Heart       Date:  2022-07

Review 6.  Aortic valve disease in diabetes: Molecular mechanisms and novel therapies.

Authors:  Ileana Manduteanu; Dan Simionescu; Agneta Simionescu; Maya Simionescu
Journal:  J Cell Mol Med       Date:  2021-09-24       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.